HIV prevalence in pregnant women in europe: Differences in assessment methods and prevalence levels across countries

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 19, Issue 3, 1998, Pages 296-305

  Cazein, Françoise ^a   Hamers, Françoise F ^a,b   Brunet, Jean Baptiste ^a  

^a Europ Ctr Epidemiol Monitoring A   (France)

^b Hospital National de Saint Maurice   (France)

Author keywords

Europe; HIV prevalence; Newborns; Pregnant women; Surveillance

Indexed keywords

ARTICLE; FEMALE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PREGNANCY; PRIORITY JOURNAL; SCREENING;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0032211889     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199811010-00013     Document Type: Article

References (56)

1. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS surveillance in Europe: quarterly report no. 54. Saint-Maurice: European Centre for the Epidemiological Monitoring of AIDS, 1997.
2. Pappaioanou M, Kashamuka M, Behets F, et al. Accurate detection of maternal antibodies to HIV in newborn whole blood dried on filter paper. AIDS 1993;7:483-8.
3. Chin J. Public health surveillance of AIDS and HIV infection. Bull World Health Organ 1990;68:592-36.
4. Couturier E, Brossard Y, Larsen C, et al. HIV infection at outcome of pregnancy in the Paris area, France. Lancet 1992;340:707-9.
5. Couturier E, Brosssard Y, Six C, et al. HIV prevalence among pregnant women in the Paris region. An unlinked anonymous survey: PREVAGEST (2nd year: 1992-1993) [in French]. Bull Epidemiol Hebdomadaire 1993;38:175-7.
6. European Centre for the Epidemiological Monitoring of AIDS. HIV prevalence among pregnant women in the Paris region. An unlinked anonymous survey: PREVAGEST 1991, 1993, 1995 [in French]. Saint-Maurice: European Centre for the Epidemiological Monitoring of AIDS, 1996.
7. Obadia Y, Rey D, Pradier C, et al. HIV prevalence among pregnant women in the PACA region [in French]. Bull Epidemiol Hebdomadaire 1992;47:226-7.
8. Rey D, Pradier C, Obadia Y, et al. HIV prevalence among pregnant women in the PACA region. An unlinked anonymous survey: PREVAGEST (2nd year: 1994) [in French]. Bull Epidemiol Hebdomadaire 1995;16:69-70.
9. Hamouda O, Willers H, Monch E, et al. HIV seroprevalence in childbearing women based on unlinked anonymous testing of newborns, 1993-1995 [abstract Mo.C.1458]. Presented at the XI International Conference on AIDS, Vancouver, British Columbia, Canada, 1996 .
10. Stegagno M, Ippolito G, Costa F, Aebischer ML, Guzzanti E. Anti-HIV 1 antibodies prevalence in parturients through newborn testing: results of the Italian anonymous serosurvey. The Italian Collaborative Study Group of HIV prevalence in newborns. Eur J Epidemiol 1993;9:430-5.
11. Ippolito G, Girardi E, Rava L, et al. Trend of HIV infection in newborns in Italy: 1990-1994. The Italian Collaborative Study Group of HIV prevalence in newborns [abstract Tu.C.2607]. Presented at the XI International Conference on AIDS, Vancouver, British Columbia, Canada, 1996.
12. Ippolito G, Stegagno M, Girardi E, et al. Temporal and geographical trends of anti-HIV-1 antibodies screening among newborns in Italy, 1990-1993. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:63-8.
13. Centre d'Estudis Epidemiologics sobre la Sida de Catalunya (CEE-SCAT). Integrated system for HIV/AIDS epidemiological surveillance in Catalonia (SIVES 1995) [in Spanish]. Barcelona: Generalitat de Catalunya, 1995.
14. Vall Mayans M, Maya A, Matas L, et al. Prevalence of maternal HIV infection in Catalonia, Spain, based on unlinked anonymous testing of newborn babies (1994) [abstract Tu.C.2480]. Presented at the XI International Conference on AIDS, Vancouver, British Columbia, Canada, 1996.
15. Centre d'Estudis Epidemiologics sobre la Sida de Catalunya (CEE-SCAT). Integrated system for HIV/AIDS epidemiological surveillance in Catalonia (SIVES 1996) [in Spanish]. Barcelona: Generalitat de Catalunya, 1996.
16. Ades AE, Parker S, Berry T, et al. Prevalence of maternal HIV-1 infection in Thames region: results from anonymous unlinked neonatal testing. Lancet 1991;337:1562-5.
17. Ades AE, Parker S, Cubitt D, et al. Two methods for assessing the risk-factor composition of the HIV-1 epidemic in heterosexual women: southeast England, 1988-1991. AIDS 1992;6:1031-6.
18. Nicoll A, Hutchinson E, Soldan K, et al. Survey of human immunodeficiency virus infection among pregnant women in England and Wales: 1990-93. Commun Dis Rep CDR Rev 1994;4:R115-20.
19. PHLS Communicable Disease Surveillance Centre. Unlinked anonymous monitoring of HIV prevalence in England and Wales: 1990-1992. Commun Dis Rep CDR Rev 1993;3:R1-11.
20. Unlinked Anonymous HIV Surveys Steering Group. Unlinked anonymous HIV prevalence monitoring program in England and Wales. Data to the end of 1993. London: Department of Health, Public Health Laboratory Services, Institute of Child Health (London). 1995.
21. Unlinked Anonymous HIV Surveys Steering Group. Unlinked anonymous HIV seroprevalence monitoring program in England and Wales. Data to the end of 1994. London: Department of Health, Public Health Laboratory Services, Institute of Child Health (London), 1995.
22. Unlinked Anonymous HIV Surveys Steering Group. Unlinked anonymous HIV seroprevalence monitoring program in England and Wales. Data to the end of 1995. London: Department of Health, Public Health Laboratory Services, Institute of Child Health (London), 1996.
23. Nicoll A, McGarrigle C, Brady AR, et al. Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom: results from national surveillance 1988-96. BMJ 1998;316:253-7.
24. Tappin DM, Girdwood RW, Follett EA, et al. Prevalence of maternal HIV infection in Scotland based on unlinked anonymous testing of newborn babies. Lancet 1991;337:1565-7.
25. Tappin DM, Girdwood RW, Follett EA, et al. Prevalence of maternal HIV infection in Scotland based on unlinked anonymous testing of newborn babies. Update. Scott Med J 1993;38:16-17.
26. Goldberg DJ, MacKinnon H, Smith R, et al. Prevalence of HIV among childbearing women and women having termination of pregnancy: multidisciplinary steering group study. BMJ 1992;304: 1082-5.
27. Tappin DM, Johnstone FD, Smith R, Girdwood RW, Follett EA, Davidson CF. Spread of maternal HIV infection in Scotland from 1990 to 1992. Scott Med J 1995;40:12-14.
28. Scottish Centre for Infection and Environmental Health. Monitoring the spread of HIV and AIDS in Scotland 1983-1996. ANSWER (AIDS news supplement to the weekly report) 1997;2:1-12.
29. Kantanen ML, Koskela P, Leinikki P. Unlinked anonymous HIV screening of pregnant women in low prevalence population. Scand J Infect Dis 1996;28:3-7.
30. Klavs I, Kristancic L, Piskur-Kosmac D. Unlinked anonymous HIV prevalence monitoring of pregnant women and STD patients in Slovenia: results for 1993. Zdrav Vestn 1994;63:659-63.
31. Klavs I, Kristancic L, Celan Lucu B, et al. Results of unlinked anonymous HIV prevalence monitoring of pregnant women, STD patients and injecting drug users in Slovenia [abstract Tu.C.200]. Presented at the XI International Conference on AIDS, Vancouver, British Columbia, Canada, 1996.
32. Nicoll A, McGarrigle C, Heptonstall J, et al. Prevalence of HIV infection in pregnant women in London and elsewhere in England. BMJ 1994:309:376-7.
33. Bindels PJ. Results of screening for HIV antibodies in pregnant women visiting infertility and abortion clinics in the region of Amsterdam in 1990 [in Dutch]. Ned Tijdschr Geneeskd 1991;135: 2123-8.
34. Bindels PJ, Mulder-Folkerts DK, Boer K, et al. The HIV prevalence among pregnant women in the Amsterdam region (1988-1991). Eur J Epidemiol 1994;10:331-8.
35. Bindels PJ, Mulder-Folkerts DK, Schutte MF, Wong FJ, Smit I, Boer K. Prevalence of HIV antibodies in pregnant women in the Amsterdam reference station research, 1988-1993 [in Dutch]. Ned Tijdschr Geneeskd 1995;139:994-7.
36. Samdal HH, Nilsen O, Magnus P. HIV-infection among pregnant women in Norway [abstract WC3279]. Presented at the VII International Conference on AIDS, Florence, Italy, 1991.
37. Nilsen O, Lystad A. HIV screening of pregnant women, military recruits and blood donors in Norway. MSIS-rapport (communicable disease report, Norway). Oslo: National Institute of Public Health, 1991;19:5.
38. Nilsen O, Lystad A, Hasseltvedt V. HIV infection: an assessment of the epidemiological situation in Norway. MSIS-rapport (communicable disease report, Norway). Oslo: National Institute of Public Health. 1993;21:9.
39. Lindgren S, Bohlin AB, Forsgren M, et al. Screening for HIV-1 antibodies in pregnancy: results from the Swedish national programme. BMJ 1993;307:1447-51.
40. Pokrovsky V, Savchenko I, Buravtsova E, et al. HIV infection surveillance in Russia in 1987-1995. Moscow: Russia AIDS Centre, 1996:4-5.
41. Pokrovski VV, Eramanova I, Arzamastsev V, Nikonova V, Mozharova G. Epidemiological surveillance for HIV infection in the USSR in 1987-1989 [abstract FC 648]. Presented at the VI International Conference on AIDS, San Francisco, 1990.
42. European Centre for the Epidemiological Monitoring of AIDS. AIDS Surveillance in Europe. Surveillance systems for HIV infection in European countries. Quarterly report No. 42. Saint-Maurice: European Centre for the Epidemiological Monitoring of AIDS, 1994.
43. Jones JL, Hutto P, Meyer P, Dowda H, Gamble WB Jr, Gunn RA. HIV seroprevalence and reasons for refusing and accepting HIV testing. Sex Transm Dis 1993;20:334-7.
44. Phillips KA. The relationship of 1988 state HIV testing policies to previous and planned voluntary use of HIV testing. J Acquir Immune Defic Syndr 1994;7:403-9.
45. De Vincenzi I, Jadand C, Couturier E, et al. Pregnancy and contraception in a French cohort of HIV-infected women. SEROCO Study Group. AIDS 1997;11:333-8.
46. Stephenson JM, Griffioen A. The effect of HIV diagnosis on reproductive experience. Study Group for the Medical Research Council Collaborative Study of Women with HIV. AIDS 1996; 10: 1683-7.
47. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-80.
48. Gwinn M, Pappaioanou M, George JR, et al. Prevalence of HIV infection in childbearing women in the United States. JAMA 1991; 265:1704-8.
49. Downs AM, Heisterkamp SH, Brunet JB, Hamers FF. Reconstruction of the HIV/AIDS epidemic among adults in the European Union and a group of low prevalence countries of central and eastern Europe. AIDS 1997;11:642-69.
50. Rezza G, Nicolosi A, Zaccarelli M, et al. Understanding the dynamics of the HIV epidemic among Italian intravenous drug users: a cross-sectional versus a longitudinal approach. J Acquir Immune Defic Syndr 1994;7:500-3.
51. Swan AV, Nicoll A. McGarrigle C, Noone A, Gill ON. An investigation assessing the fraction of Human immunodeficiency virus infection attributable to ethnic group variations in risk. Int J Epidemiol 1995;24(Suppl 1):S15-20.
52. Batter V, Mateka B, Nsuamei X, et al. High HIV-1 incidence in young women masked by stable overall seroprevalence among childbearing women in Kinshasa, Zaire: estimating incidence from serial seroprevalence data. AIDS 1994;8:811-17.
53. Goubar A, Costagliola D. Estimate of HIV incidence in childbearing women in the Paris area, France [letter]. AIDS 1997;11:699-701.
54. Hamers FF, Downs AM, Infuso A, Brunet JB. Diversity of the HIV/AIDS epidemic in Europe. AIDS 1998;12(Suppl A).
55. Kobyshcha Y, Shcherbinskaya A. Khodakevich L, et al. HIV infection among drug users in Ukraine beginning ot the epidemic [abstract Tu.C.204]. Presented at the XI International Conference on AIDS, Vancouver, British Columbia, Canada, 1996.
56. Obadia Y, Rey D, Moatti JP, et al. HIV prenatal screening in south-eastern France: differences in seroprevalence and screening policies by pregnancy outcome. AIDS Care 1994;6:29-38.